RASA1 and NTRK1

  • Number of citations of the paper that reports this interaction (PMID 8384556)
  • 22
  • Data Source:
  • HPRD (in vivo, in vitro)

RASA1

NTRK1

Gene Name RAS p21 protein activator (GTPase activating protein) 1 neurotrophic tyrosine kinase, receptor, type 1
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 73 interactors: ABL1 AFAP1L2 ANXA6 APP ARHGAP1 ARHGAP5 AURKB BBS10 BCR BIRC5 CASP3 CASP7 CAV2 CD5 CSF1R CSK DNAJA3 DOK1 DOK2 DOK4 EGFR EIF1 EPHA2 EPHB2 EPHB3 ERBB2 ERBB3 ERBB4 EZH2 FES G3BP1 GNB2L1 GRB2 HCK HRAS HSPD1 HTT IGF1R INSR KDR KHDRBS1 KIT LCK LYN MAGI1 MAP4K4 NCK1 NTRK1 PAG1 PDE6D PDGFRB PIK3R1 PTK2B PTPRC PXN RAB5A RAP1A SERPINA4 SHC1 SLC9A2 SOCS3 SPSB1 SRC STAU1 SYK SYN1 TRMT2A WWP1 WWP2 XRCC6 YES1 ZAP70 ZNF579 36 interactors: ABL1 ARHGAP32 CAV1 CRK DNAJA3 DYNLL1 FRS2 FRS3 GIPC1 GRB2 IRS1 IRS2 KIDINS220 MAPK3 MATK NEDD4 NEDD4L NGF NGFR NTF3 PIK3R1 PLCG1 PTPN1 PTPN11 RAP1A RASA1 RASGRF1 RUSC1 SH2B1 SH2B2 SHC1 SHC2 SHC3 SQSTM1 TRAF6 UBB
Entrez ID 5921 4914
HPRD ID 00745 01869
Ensembl ID ENSG00000145715 ENSG00000198400
Uniprot IDs B4DTL2 E9PGC0 P20936 Q59GK3 P04629
PDB IDs 1WER 1WQ1 2GQI 2GSB 2J05 2J06 2M51 4FSS 1HE7 1SHC 1WWA 1WWW 2IFG 4AOJ 4F0I 4GT5
Enriched GO Terms of Interacting Partners?
Tagcloud ?
adaptors  assumptions  combinatorial  complexity  cooperativity  dealt  demodification  descriptions  disallow  hinders  hoc  lumped  modelling  obstacle  ode  odes  ordinary  pharmacology  phosphatases  plcgamma1  reasonably  relaxed  retaining  shc1  shp2  simulate  subdomains  tyrosines  unphosphorylated 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  tpm3  transforming  trka  trkb  trkc 
Tagcloud (Difference) ?
adaptors  assumptions  combinatorial  complexity  cooperativity  dealt  demodification  descriptions  disallow  hinders  hoc  lumped  modelling  obstacle  ode  odes  ordinary  pharmacology  phosphatases  plcgamma1  reasonably  relaxed  retaining  shc1  shp2  simulate  subdomains  tyrosines  unphosphorylated 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  tpm3  transforming  trka  trkb  trkc 
Tagcloud (Intersection) ?